NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/18/2026
Back to search
Official data from USPTO
MEDIX BIOCHEMICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
06/19/2026
Trademark type
Combined
Nice classes
1, 5, 10
Filing date
07/01/2013
Registration date
09/02/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2025
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
5
Owner type
16
Owner location
Espoo, FI
Examiner
REINHART, MEGHAN M
Current location
Historical data usage
Holders and representatives
Holders
Oy Medix Biochemica Ab
Oy Medix Biochemica Ab
Representatives
Roger H. Bora Thompson Hine LLP
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for medical research; reagent medium for medical research
Class 5
Diagnostic preparations for medical use; reagent medium for medical purposes
Class 10
Medical apparatus and instrumentsdiagnostic testing apparatus and instruments for medical usedetectors and analyzers for use in in vitro diagnostic testing procedurescardiovascular diagnosis and screeningdiabetes monitoring and diagnosispregnancy monitoringdetectingscreening and monitoring infectious diseasesmonitoring and diagnosing metabolic functionsdiagnosing and monitoring inflammatory diseasesblood analysisurine analysisstool analysisfecal analysissaliva analysisanalysis of oral fluidsanalysis of amniotic fluidsanalysis of CSF (cervicospinalfluid)analysis of ascitesanalysis of pleural fluidsanalysis of exudateanalysis of cervicalvaginal and cervico-vaginal secretionsdiagnosis of skin disordersthyroid disease screeningscreening for cancer; in-vitro diagnostic test kits for medical purposes for professional or home use comprised of collection pads or swabscollection loops or vialstest strips capable of visual or instrument read out of test results and/or vials of developer solution or reagentswhich use oral fluidurinefecesamniotic fluidvaginal secretionscervical secretionscervico-vaginal secretionsfinger stick or venipuncture whole bloodplasmaserumexudateskinCSF (cervicospinalfluid)ascitespleural fluidsother bodily fluids and specimens for use in detecting antibodiesantigenvirusesbacteria and other pathogensdisease markers and metabolitesfecal occult bloodhormonesvitaminsproteinsnucleic acidstoxinsdrugs and their metabolitesdrugs of abuse and chemicals
Publications
History of USPTO decisions and trademark events.
47 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/14/2026
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/09/2026
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/24/2026
INPC
INVALIDATION PROCESSED
03/24/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/19/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/03/2025
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
04/15/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/03/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
02/03/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/28/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
07/25/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/02/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/15/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/24/2021
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/29/2021
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
03/29/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/26/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
02/23/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/02/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/16/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/02/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/27/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/12/2015
FIMP
FINAL DISPOSITION PROCESSED
02/12/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/02/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2014
DOCK
ASSIGNED TO EXAMINER
07/08/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/17/2014
PUBO
PUBLISHED FOR OPPOSITION
06/17/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/15/2014
ALIE
ASSIGNED TO LIE
05/15/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2014
RFNP
REFUSAL PROCESSED BY IB
11/24/2013
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/07/2013
RFRR
REFUSAL PROCESSED BY MPU
11/07/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/07/2013
CNRT
NON-FINAL ACTION WRITTEN
11/06/2013
DOCK
ASSIGNED TO EXAMINER
11/06/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/01/2013
Continuous trademark protection
Get notified about every new filing that threatens MEDIX BIOCHEMICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.